James Huber
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Hepatology top 5%
- Immunology
- Co-authors
- Daniel J. HicklinHitoshi YoshijiYasuhide IkenakaHiroshi FukuiHirohisa TsujinoueToshiya NakataniShigeki KuriyamaJunichi Yoshii
- Topics
- Angiogenesis and VEGF in Cancer (8 papers)Cancer, Hypoxia, and Metabolism (4 papers)Vascular Tumors and Angiosarcomas (2 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- United StatesJapanCanada
In The Last Decade
James Huber
10 papers receiving 538 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 382
- Cancer Research 194
- Oncology 159
- Hepatology 125
- Immunology 56
Countries citing papers authored by James Huber
This map shows the geographic impact of James Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Huber more than expected).
Fields of papers citing papers by James Huber
This network shows the impact of papers produced by James Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Huber. The network helps show where James Huber may publish in the future.
Co-authorship network of co-authors of James Huber
This figure shows the co-authorship network connecting the top 25 collaborators of James Huber. A scholar is included among the top collaborators of James Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Huber. James Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies. | 21 |
| 2 | 3 | |
| 3 | 120 | |
| 4 | A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers | 1 |
| 5 | 128 | |
| 6 | Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. | 26 |
| 7 | 126 | |
| 8 | 49 | |
| 9 | 84 | |
| 10 | 6 |
About James Huber
James Huber is a scholar working on Immunology and Allergy, Cancer Research and Modeling and Simulation, having authored 10 papers that have together received 564 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Hepatology (125 citations), Cancer Research (194 citations) and Oncology (159 citations). James Huber has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Daniel J. Hicklin, Hitoshi Yoshiji, Yasuhide Ikenaka, Hiroshi Fukui, Hirohisa Tsujinoue, Toshiya Nakatani, Shigeki Kuriyama, Junichi Yoshii, Ryuichi Noguchi and Hiroo Imazu. Their work appears in journals such as Hepatology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.